Interview: Tim Clover, Chief Executive, Moonray Healthcare
publication date: Feb 4, 2011
Tim Clover is chief executive at Moonray Healthcare, which manages balance sheet healthcare investments for fund group Fidelity International. Moonray has invested £50m to date creating Optegra, which it plans to grow into an international chain of opthalomology centres. Most of the money has already gone on five clinics in the UK and the purchase of Augentis GmbH, a chain of four outlets in Germany. Clover has plans for China and thinks other sectors of ambulatory surgery hold similar promise to ophthalmology. Previously, Tim was Vice President EMEA for Eyecare with Allergan and a founder of Advanced Medical Optics, which was spun off from Allergan and listed on the New York Stock Exchange in June 2002.
To get full access to this article you will need to subscribe to Healthcare Europa. This gives you indepth quality coverage of how the dynamic private healthcare sector is developing across Europe.
Please click here to look at subscription options.
You can, however, register for free to recieve limited access. This gives you access to headlines and the first lines of stories and you can ask us to send you a news email with headlines 40 times a year. As a free registrant, you can also view our blog. Click here to sign up for limited access free registration.
